Safety and reliability of hepatic radiofrequency ablation near the inferior vena cava: An experimental study

International Journal of Hyperthermia

Volumn 27, Issue 2, 2011, Pages 116-123

  Huang, Jiansheng ^a   Li, Tingjun ^a   Liu, Nianzhou ^a   Chen, Ming ^a   He, Zhenping ^a   Ma, Kuansheng ^a   Bie, Ping ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Inferior vena cava; liver; radiofrequency ablation; reliability; safety

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD FLOW VELOCITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ELECTRODE; EXPERIMENTAL DOG; FEASIBILITY STUDY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; INFERIOR CAVA VEIN; LIVER; LIVER CELL; MALE; NONHUMAN; PATIENT SAFETY; RADIOFREQUENCY ABLATION; TREATMENT DURATION; VASCULAR NECROSIS; VEIN BLOOD FLOW; VEIN DIAMETER; VEIN WALL;

ANIMALS; CATHETER ABLATION; DOGS; FEMALE; LIVER; MALE; REGIONAL BLOOD FLOW; VENA CAVA, INFERIOR;

EID: 79951609825     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2010.508762     Document Type: Article

References (28)

1. Forner A, Bruix J. Locoregional treatment for hepatocellular carcinoma: From clinical exploration to robust clinical data, changing standards of care. Hepatology 2008;47:5-9.
2. Haemmerich D, Laeseke PF. Thermal tumour ablation: Devices, clinical applications and future directions. Int J Hyperthermia 2005;21:755-760. (Pubitemid 41807102)
3. Garrean S, Hering J, Saied A, Helton WS, Espat NJ. Radiofrequency ablation of primary and metastatic liver tumors: A critical review of the literature. Am J Surg 2008;195:508-511.
4. Sutherland LM, Williams JA, Padbury RT, Gotley DC, Stokes B, Maddern GJ. Radiofrequency ablation of liver tumors: A systematic review. Arch Surg 2006;141:181-184.
5. Nakai M, Sato M, Sahara S, Kawai N, Tanihata H, Kimura M, Terada M. Radiofrequency ablation in a porcine liver model: Effects of transcatheter arterial embolization with iodized oil on ablation time, maximum output, and coagulation diameter as well as angiographic characteristics. World J Gastroenterol 2007;13:2841-2845. (Pubitemid 47007899)
6. Yoshimoto T, Kotoh K, Horikawa Y, Kohjima M, Morizono S, Yamashita S, Enjoji M, Nakamuta M. Decreased portal flow volume increases the area of necrosis caused by radio frequency ablation in pigs. Liver Int 2007;27:368-372. (Pubitemid 46416628)
7. Thanos L, Mylona S, Galani P, Pomoni M, Pomoni A, Koskinas I. Overcoming the heat-sink phenomenon: Successful radiofrequency thermal ablation of liver tumors in contact with blood vessels. Diagn Interv Radiol 2008;14:51-54.
8. Teratani T, Yoshida H, Shiina S, Obi S, Sato S, Tateishi R, Mine N, Kondo Y, Kawabe T, Omata M. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology 2006;43:1101-1105.
9. Wong SN, Lin CJ, Lin CC, Chen WT, Cua IH, Lin SM. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations. Am J Roentgenol 2008;190: W187-W192.
10. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381-385.
11. Schirmang TC, Dupuy DE. Image-guided thermal ablation of nonresectable hepatic tumors using the Cool-Tip radiofrequency ablation system. Expert Rev Med Devices 2007;4:803-806.
12. Crocetti L, Lencioni R. Thermal ablation of hepatocellular carcinoma. Cancer Imaging 2008;8:19-24.
13. Quan-Da Liu, Kuan-Sheng Ma, Zhen-Ping He, Jun. Ding, Xue-Quan Huang, Jia-Hong Dong. Experimental study on the feasibility and safety of radiofrequency ablation for secondary splenomegaly and hypersplenism. World Gastroenterol, 2003;9:813-817. (Pubitemid 36531567)
14. McMahon BJ. Natural history of chronic hepatitis B-clinical implications. Medscape J Med 2008;10:91-95.
15. Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS. Management of hepatitis B: Summary of a clinical research workshop. Hepatology 2007;45:1056-1060.
16. Shen P, Fleming S, Westcott C, Challa V. Laparoscopic radiofrequency ablation of the liver in proximity to major vasculature: Effect of the Pringle maneuver. J Surg Oncol 2003;83:36-40.
17. Burdío F, Navarro A, Sousa R, Burdío JM, Güemes A, Gonzalez A, Cruz I, Castiella T, Lozano R, Berjano E, et al. Evolving technology in bipolar perfused radiofrequency ablation: Assessment of efficacy, predictability and safety in a pig liver model. Eur Radiol 2006;16:1826-1831.
18. Ng KK, Poon RT, Lam CM, Yuen J, Tso WK, Fan ST. Efficacy and safety of radiofrequency ablation for perivascular hepatocellular carcinoma without hepatic inflow occlusion. Br J Surg 2006;93:440-446.
19. Lee JM, Han JK, Eoh H, Kim SH, Lee JY, Lee MW, Choi BI. Intraoperative radiofrequency ablation using a loop internally cooled-perfusion electrode: In vitro and in vivo experiments. J Surg Res 2006;131:215-220.
20. Raggi MC, Schneider A, Härtl F, Wilhelm D, Wirnhier H, Feussner H. A family of new instruments for laparoscopic radiofrequency ablation of malignant liver lesions. Minim Invasive Ther Allied Technol 2006;15:42-46.
21. Mertyna P, Dewhirst MW, Halpern E, Goldberg W, Goldberg SN. Radiofrequency ablation: The effect of distance and baseline temperature on thermal dose required for coagulation. Int J Hyperthermia 2008;24:550-559.
22. Casaril A, Abu Hilal M, Harb A, Campagnaro T, Mansueto G, Nicoli N. The safety of radiofrequency thermal ablation in the treatment of liver malignancies. Eur J Surg Onco 2008;134:668-672. (Pubitemid 351671971)
23. Kobayashi M, Ikeda K, Kawamura Y, Hosaka T, Sezaki H, Yatsuji H, Akuta N, Suzuki F, Suzuki Y, Arase Y, et al. Randomized controlled trial for the efficacy of hepatic arterial occlusion during radiofrequency ablation for small hepatocellular carcinoma - Direct ablative effects and a long-term outcome. Liver Int 2007;27:353-257.
24. Poggi G, Riccardi A, Quaretti P, Teragni C, Delmonte A, Amatu A, Saini G, Mazzucco M, Bernardo A, Palumbo R, et al. Complications of percutaneous radiofrequency thermal ablation of primary and secondary lesions of the liver. Anticancer Res 2007;27:2911-2915.
25. Nouso K, Shiraga K, Uematsu S, Okamoto R, Harada R, Takayama S, Kawai W, Kimura S, Ueki T, Okano N, et al. Prediction of the ablated area by the spread of microbubbles during radiofrequency ablation of hepatocellular carcinoma. Liver Int 2005;25:967-971.
26. Kisaka Y, Hirooka M, Kumagi T, Uehara T, Hiasa Y, Kumano S, Tanaka H, Michitaka K, Horiike N, Mochizuki T, et al. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation. Liver Int 2006;26:1241-1245.
27. Nicolau C, Vilana R, Bianchi L. Early-stage hepatocellular carcinoma: The high accuracy of real-time contrast-enhanced ultrasonography in the assessment of response to percutaneous treatment. Eur Radiol 2007;17: F80-F85.
28. Lencioni R, Della Pina C, Crocetti L, Bozzi E, Cioni D. Clinical management of focal liver lesions: The key role of real-time contrast-enhanced US. Eur Radiol 2007;17: F73-F77.